大卫Geleta

My role as a data scientist involves integrating vast amounts of medical knowledge, creating intelligent applications powered by knowledge graphs, and enabling other scientists in exploiting knowledge graphs to derive new insights to support drug discovery and development. 

I joined AstraZeneca in 2019 from Babylon Health and immediately felt supported by the company and by my team. They have helped me to settle in quickly and I can feel the impact of my work.

I recently delivered a prototype for a Biological Insights Knowledge Graph comprised of literature derived knowledge, public data sources, and proprietary clinical and pre-clinical multi-layered data including screening, 总会在, multi-omics, 成像, CRISPR, clinical and electronic health records. Together with our scientists, our aim is to interrogate this knowledge graph to discover novel drug targets, aid pattern identification defining distinct patient groups and biomarkers, understand drug mechanism of action, and build predictive models for precision medicine.

In my opinion AstraZeneca is one of the world’s most exciting biopharma companies because in recent years it has fully embraced AI across the whole of its operations.